from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1539/lspA

LFCtreatmentdescriptionclass of inhibitor

-0.188

Amikacinug/mL Amikacintranslation

0.142

Cap5-10ug/mL Capreomycintranslation

-0.258

Rox10-50 ug/mL Roxithromycintranslation

-0.119

SM2-5 ug/mL Streptomycintranslation

-1.283

Tet5-10 ug/mL Tetracyclinetranslation

-0.281

Rif0.2-5ug/mL Rifampicintranscription

0.111

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.833

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.234

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.076

CPZ10-50 ug/mL Chlorpromazinerespiration

1.095

Clofazimine10-13 ug/mL Clofaziminerespiration

0.129

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.627

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.473

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.357

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.736

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.572

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.005

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.759

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.076

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

3.218

KCN5-20 ug/mL Potassium cyaniderespiration

0.417

NaN30.2-2 mM Sodium aziderespiration

0.027

Nigericin50 uM Nigericinrespiration

-0.220

TRC10-150 ug/mL Triclosanrespiration

-0.462

TRZ10-25 ug/mL Thioridazinerespiration

-0.606

Valinomycin0.5-10 uM Valinomycinrespiration

-0.440

ZnSO42 mM ZnSO4respiration

-0.061

menadione6-10 ug/mL Menadionerespiration

-0.076

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.279

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.488

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.541

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.899

NRP_1Non-replicating persistence stage 1dosRassociated

-0.431

Amp0.2mg/mL AmpicillincellWall

-0.433

Cephalexin20-100 ug/mL CephalexincellWall

0.059

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.050

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.672

EMB10-20 ug/mL EthambutolcellWall

0.001

Eta12-40 ug/mL EthionamidecellWall

0.254

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.209

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.832

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.669

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.149

BZA0.12 mg/mL BenzamidearomaticAmides

0.023

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.093

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.302

H2O24 mM hydrogen peroxideDNAdamaging

-0.136

Levo10 ug/mL LevofloxacinDNAdamaging

-0.365

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.388

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.069

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.201

UVUV-irradiationDNAdamaging

0.272

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.540

Antimycin12.5-50 ug/mL Antimycin A?

-0.285

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.404

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.515

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.541

PA8240.2-2 ug/mL PA-824?

2.576

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.778

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.592

Verapamil50 uM Verapamil?

-0.118

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.194

methoxatin10-20 ug/mL Methoxatin?